Abstract:Background: Bladder cancer is the most common malignancy of the urinary system, and the search for new and reliable biomarkers has important clinical significance for the personalized treatment of bladder cancer. This study aims to explore the correlation between nuclear proliferation antigen (Ki-67) or Profilin-1 (PFN1) levels, clinicopathological characteristics, and postoperative prognosis in patients with bladder cancer. Methods: Patients with bladder cancer who underwent transurethral resection of bladder cancer tumor in The Fourth Affiliated Hospital of Soochow University, hospital from January 2019 to January 2021 were selected as the study group (n = 60), and patients with benign lesions of bladder cancer during the same period were selected as the control group (n = 60). The expression of Ki-67 and PFN1 in tumor and bladder tissues of the two groups was analyzed. Ki-67 recorded the patient's pathological parameters and calculated the patient's postoperative prognosis. The correlation between Ki-67 and PFN1 expression levels, pathological parameters, and postoperative prognosis was analyzed. Results: The positive expression rates of Ki-67 and PFN1 in the study group were 63.33% and 73.33%, respectively, which were significantly higher than the positive expression rates in the control group (χ2 = 14.803, 17.757, p < 0.001). The positive expression rates of Ki-67 and PFN1 were related to histological grade, clinical stage, infiltration, and lymph node metastasis, and the differences were statistically significant (p 0.05). The survival time and three-year survival rate of the Ki-67 positive expression group were significantly lower than those of the Ki-67 negative expression group (p < 0.05). The survival time and three-year survival rate of the PFN1 positive expression group were significantly lower than those of the PFN1 negative expression group (p < 0.05). Conclusion: The positive expression rates of Ki-67 and PFN1 in bladder tumor tissue are significantly higher than those in bladder tissue, and pathological pattern, histological grade, clinical stage, infiltration, and lymph node metastasis are related to the positive expression rates of Ki-67 and PFN1, and different genders, ages, tumors diameter and vascular invasion are not related to the positive expression rates of Ki-67 and PFN1. The survival time and three-year survival rates of bladder cancer patients with Ki-67 positive and PFN1 positive expression are shorter.

The Correlation Between Recurrence of Superf Icial Bladder Cancer and Ki-67, P63 Expression

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

The Expressions of Survlvin,p53 and Ki-67 in Bladder Cancer

Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer

The Correlation Between Recurrence and the Expression of Ki-67 and P53 in Meningiomas

The Expression of p16 and p53 Tumor Suppressor Gene in Bladder Carcinoma

Multi-target fluorescence in situ hybridization for prediction of recurrent superficial bladder cancer

Relationship of P16 and Ki67 in Recurrence of HPV Infection and Cervical Intraepithelial Neoplasia.

Clinical Analysis of Some Recurrence Information in Bladder Transitional Cell Carcinoma

The Correlation and Expression of Survivin and PCNA in Bladder Transitional Carcinoma

Correlation Between the Expression of Androgen Receptor Mrna and the Long-Term Tumor-Specific and Recurrence-Free Survival Rate in Patients with T1 Bladder Cancer

The Expression of PCNA Protein and Its Relationship with Recurrence of Bladder Cancer

Relationship between the expression of mutant P53 and PCNA and their clinical significances in transitional cell carcinoma of the bladder

[Multivariate analysis of recurrence in T1 bladder transitional cell carcinoma].

Correlation between Ki-67 or Profilin-1 Expression Levels, Clinicopathological Characteristics and Postoperative Prognosis in Patients with Bladder Cancer

The correlation of c-FLIP and p53 protein expression and tumor prognosis in bladder cancer

The Relationship Between the Expression of Mutant p53 and VEGF and the Clinical Significances in Transitional Cell Carcinoma of the Bladder

Expression and Significance of P63 and Survivin Protein in Lung Carcinoma

Relationship Between Expression of Ki67 Antigen and Clinicopathological Features and Prognosis of Primary Laryngeal Squamous Cell Carcinoma

Expression and Analysis of Survivin and DNA Ploidy Analysis in Bladder Transitional Carcinoma